Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
Condition(s):Liposarcoma; LeiomyosarcomaLast Updated:November 1, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Liposarcoma; LeiomyosarcomaLast Updated:November 1, 2021Completed
Condition(s):Liposarcoma; Advanced Solid TumorLast Updated:January 23, 2024Recruiting
Condition(s):Liposarcoma, DedifferentiatedLast Updated:March 26, 2024Recruiting
Condition(s):Liposarcoma; Atypical Lipomatous TumorLast Updated:March 14, 2022Recruiting
Condition(s):Sarcoma; LiposarcomaLast Updated:November 6, 2017Completed
Condition(s):Well-differentiated/Dedifferentiated LiposarcomaLast Updated:March 27, 2024Recruiting
Condition(s):LiposarcomaLast Updated:June 7, 2023Completed
Condition(s):Liposarcoma,MyxoidLast Updated:May 7, 2014Completed
Condition(s):Liposarcoma; Soft Tissue SarcomaLast Updated:November 23, 2016Unknown status
Condition(s):Advanced Liposarcoma or LeiomyosarcomaLast Updated:August 26, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.